nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—Epirubicin—thyroid cancer	0.301	0.391	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—thyroid cancer	0.16	0.208	CbGbCtD
Norfloxacin—CYP3A7—Sorafenib—thyroid cancer	0.0722	0.0939	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0722	0.0939	CbGbCtD
Norfloxacin—CYP3A5—Sorafenib—thyroid cancer	0.0542	0.0705	CbGbCtD
Norfloxacin—CYP1A2—Sorafenib—thyroid cancer	0.0403	0.0524	CbGbCtD
Norfloxacin—CYP3A4—Vandetanib—thyroid cancer	0.035	0.0456	CbGbCtD
Norfloxacin—CYP3A4—Sorafenib—thyroid cancer	0.0211	0.0275	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—thyroid cancer	0.0128	0.0167	CbGbCtD
Norfloxacin—TOP2A—Erlotinib—Vandetanib—thyroid cancer	0.00246	0.312	CbGdCrCtD
Norfloxacin—TOP2A—Afatinib—Vandetanib—thyroid cancer	0.00161	0.204	CbGdCrCtD
Norfloxacin—TOP2A—Gefitinib—Vandetanib—thyroid cancer	0.00141	0.178	CbGdCrCtD
Norfloxacin—Dry mouth—Vandetanib—thyroid cancer	0.000907	0.00411	CcSEcCtD
Norfloxacin—Oedema—Vandetanib—thyroid cancer	0.000889	0.00402	CcSEcCtD
Norfloxacin—Thrombocytopenia—Vandetanib—thyroid cancer	0.000871	0.00394	CcSEcCtD
Norfloxacin—Nystagmus—Epirubicin—thyroid cancer	0.00087	0.00394	CcSEcCtD
Norfloxacin—Blister—Epirubicin—thyroid cancer	0.000862	0.0039	CcSEcCtD
Norfloxacin—Ventricular arrhythmia—Epirubicin—thyroid cancer	0.00084	0.0038	CcSEcCtD
Norfloxacin—Albuminuria—Epirubicin—thyroid cancer	0.000832	0.00377	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00081	0.00367	CcSEcCtD
Norfloxacin—Nystagmus—Doxorubicin—thyroid cancer	0.000805	0.00364	CcSEcCtD
Norfloxacin—Insomnia—Vandetanib—thyroid cancer	0.000804	0.00364	CcSEcCtD
Norfloxacin—Paraesthesia—Vandetanib—thyroid cancer	0.000799	0.00361	CcSEcCtD
Norfloxacin—Erythema multiforme—Sorafenib—thyroid cancer	0.000798	0.00361	CcSEcCtD
Norfloxacin—Blister—Doxorubicin—thyroid cancer	0.000798	0.00361	CcSEcCtD
Norfloxacin—Dyspnoea—Vandetanib—thyroid cancer	0.000793	0.00359	CcSEcCtD
Norfloxacin—Tinnitus—Sorafenib—thyroid cancer	0.000787	0.00356	CcSEcCtD
Norfloxacin—Dyspepsia—Vandetanib—thyroid cancer	0.000783	0.00354	CcSEcCtD
Norfloxacin—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.000777	0.00351	CcSEcCtD
Norfloxacin—Decreased appetite—Vandetanib—thyroid cancer	0.000773	0.0035	CcSEcCtD
Norfloxacin—Albuminuria—Doxorubicin—thyroid cancer	0.00077	0.00348	CcSEcCtD
Norfloxacin—Glycosuria—Epirubicin—thyroid cancer	0.000767	0.00347	CcSEcCtD
Norfloxacin—Fatigue—Vandetanib—thyroid cancer	0.000767	0.00347	CcSEcCtD
Norfloxacin—Constipation—Vandetanib—thyroid cancer	0.00076	0.00344	CcSEcCtD
Norfloxacin—Erythema—Sorafenib—thyroid cancer	0.000735	0.00333	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000727	0.00329	CcSEcCtD
Norfloxacin—Dysgeusia—Sorafenib—thyroid cancer	0.00072	0.00326	CcSEcCtD
Norfloxacin—Glycosuria—Doxorubicin—thyroid cancer	0.00071	0.00321	CcSEcCtD
Norfloxacin—Jaundice cholestatic—Epirubicin—thyroid cancer	0.000707	0.0032	CcSEcCtD
Norfloxacin—Muscle spasms—Sorafenib—thyroid cancer	0.000707	0.0032	CcSEcCtD
Norfloxacin—Abdominal pain—Vandetanib—thyroid cancer	0.000703	0.00318	CcSEcCtD
Norfloxacin—Body temperature increased—Vandetanib—thyroid cancer	0.000703	0.00318	CcSEcCtD
Norfloxacin—Lacrimation increased—Epirubicin—thyroid cancer	0.000674	0.00305	CcSEcCtD
Norfloxacin—Angioedema—Sorafenib—thyroid cancer	0.000672	0.00304	CcSEcCtD
Norfloxacin—Leukopenia—Sorafenib—thyroid cancer	0.000658	0.00298	CcSEcCtD
Norfloxacin—Dysarthria—Epirubicin—thyroid cancer	0.000657	0.00297	CcSEcCtD
Norfloxacin—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.000654	0.00296	CcSEcCtD
Norfloxacin—Creatinine increased—Epirubicin—thyroid cancer	0.000653	0.00295	CcSEcCtD
Norfloxacin—Asthenia—Vandetanib—thyroid cancer	0.000638	0.00289	CcSEcCtD
Norfloxacin—Pruritus—Vandetanib—thyroid cancer	0.000629	0.00285	CcSEcCtD
Norfloxacin—Arthralgia—Sorafenib—thyroid cancer	0.000626	0.00283	CcSEcCtD
Norfloxacin—Myalgia—Sorafenib—thyroid cancer	0.000626	0.00283	CcSEcCtD
Norfloxacin—Lacrimation increased—Doxorubicin—thyroid cancer	0.000624	0.00282	CcSEcCtD
Norfloxacin—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.000621	0.00281	CcSEcCtD
Norfloxacin—Dry mouth—Sorafenib—thyroid cancer	0.000612	0.00277	CcSEcCtD
Norfloxacin—Diarrhoea—Vandetanib—thyroid cancer	0.000608	0.00275	CcSEcCtD
Norfloxacin—Dysarthria—Doxorubicin—thyroid cancer	0.000608	0.00275	CcSEcCtD
Norfloxacin—Creatinine increased—Doxorubicin—thyroid cancer	0.000604	0.00273	CcSEcCtD
Norfloxacin—Anaphylactic shock—Sorafenib—thyroid cancer	0.0006	0.00271	CcSEcCtD
Norfloxacin—Dizziness—Vandetanib—thyroid cancer	0.000588	0.00266	CcSEcCtD
Norfloxacin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000587	0.00266	CcSEcCtD
Norfloxacin—Blood urea increased—Epirubicin—thyroid cancer	0.000587	0.00265	CcSEcCtD
Norfloxacin—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.000575	0.0026	CcSEcCtD
Norfloxacin—Anorexia—Sorafenib—thyroid cancer	0.000572	0.00259	CcSEcCtD
Norfloxacin—Vomiting—Vandetanib—thyroid cancer	0.000565	0.00256	CcSEcCtD
Norfloxacin—Mouth ulceration—Epirubicin—thyroid cancer	0.000562	0.00254	CcSEcCtD
Norfloxacin—Rash—Vandetanib—thyroid cancer	0.000561	0.00254	CcSEcCtD
Norfloxacin—Dermatitis—Vandetanib—thyroid cancer	0.00056	0.00253	CcSEcCtD
Norfloxacin—Headache—Vandetanib—thyroid cancer	0.000557	0.00252	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000547	0.00247	CcSEcCtD
Norfloxacin—Hypertonia—Epirubicin—thyroid cancer	0.000545	0.00246	CcSEcCtD
Norfloxacin—Blood urea increased—Doxorubicin—thyroid cancer	0.000543	0.00246	CcSEcCtD
Norfloxacin—Dyspnoea—Sorafenib—thyroid cancer	0.000535	0.00242	CcSEcCtD
Norfloxacin—Nausea—Vandetanib—thyroid cancer	0.000528	0.00239	CcSEcCtD
Norfloxacin—Dyspepsia—Sorafenib—thyroid cancer	0.000528	0.00239	CcSEcCtD
Norfloxacin—Decreased appetite—Sorafenib—thyroid cancer	0.000521	0.00236	CcSEcCtD
Norfloxacin—Mouth ulceration—Doxorubicin—thyroid cancer	0.00052	0.00235	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000519	0.00235	CcSEcCtD
Norfloxacin—Fatigue—Sorafenib—thyroid cancer	0.000517	0.00234	CcSEcCtD
Norfloxacin—Photosensitivity—Epirubicin—thyroid cancer	0.000514	0.00232	CcSEcCtD
Norfloxacin—Constipation—Sorafenib—thyroid cancer	0.000513	0.00232	CcSEcCtD
Norfloxacin—Hypertonia—Doxorubicin—thyroid cancer	0.000504	0.00228	CcSEcCtD
Norfloxacin—Hepatic failure—Epirubicin—thyroid cancer	0.000502	0.00227	CcSEcCtD
Norfloxacin—Eye pain—Epirubicin—thyroid cancer	0.0005	0.00226	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000491	0.00222	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00048	0.00217	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000478	0.00216	CcSEcCtD
Norfloxacin—Urticaria—Sorafenib—thyroid cancer	0.000477	0.00216	CcSEcCtD
Norfloxacin—Photosensitivity—Doxorubicin—thyroid cancer	0.000475	0.00215	CcSEcCtD
Norfloxacin—Abdominal pain—Sorafenib—thyroid cancer	0.000474	0.00215	CcSEcCtD
Norfloxacin—Body temperature increased—Sorafenib—thyroid cancer	0.000474	0.00215	CcSEcCtD
Norfloxacin—Dermatitis bullous—Epirubicin—thyroid cancer	0.000472	0.00214	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000466	0.00211	CcSEcCtD
Norfloxacin—Hepatic failure—Doxorubicin—thyroid cancer	0.000464	0.0021	CcSEcCtD
Norfloxacin—Eye pain—Doxorubicin—thyroid cancer	0.000462	0.00209	CcSEcCtD
Norfloxacin—Hypoglycaemia—Epirubicin—thyroid cancer	0.000462	0.00209	CcSEcCtD
Norfloxacin—Osteoarthritis—Epirubicin—thyroid cancer	0.000451	0.00204	CcSEcCtD
Norfloxacin—Diplopia—Epirubicin—thyroid cancer	0.000451	0.00204	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000442	0.002	CcSEcCtD
Norfloxacin—Hypersensitivity—Sorafenib—thyroid cancer	0.000442	0.002	CcSEcCtD
Norfloxacin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000437	0.00198	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000431	0.00195	CcSEcCtD
Norfloxacin—Asthenia—Sorafenib—thyroid cancer	0.00043	0.00195	CcSEcCtD
Norfloxacin—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000428	0.00194	CcSEcCtD
Norfloxacin—Pruritus—Sorafenib—thyroid cancer	0.000424	0.00192	CcSEcCtD
Norfloxacin—Ataxia—Epirubicin—thyroid cancer	0.000424	0.00192	CcSEcCtD
Norfloxacin—Blood creatinine increased—Epirubicin—thyroid cancer	0.000423	0.00191	CcSEcCtD
Norfloxacin—TOP2A—Daunorubicin—Epirubicin—thyroid cancer	0.000418	0.0529	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Epirubicin—thyroid cancer	0.000418	0.0529	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Epirubicin—thyroid cancer	0.000418	0.0529	CbGdCrCtD
Norfloxacin—Osteoarthritis—Doxorubicin—thyroid cancer	0.000417	0.00189	CcSEcCtD
Norfloxacin—Diplopia—Doxorubicin—thyroid cancer	0.000417	0.00189	CcSEcCtD
Norfloxacin—Liver function test abnormal—Epirubicin—thyroid cancer	0.000416	0.00188	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000412	0.00186	CcSEcCtD
Norfloxacin—Diarrhoea—Sorafenib—thyroid cancer	0.00041	0.00186	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000406	0.00184	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000406	0.00184	CcSEcCtD
Norfloxacin—Dizziness—Sorafenib—thyroid cancer	0.000397	0.00179	CcSEcCtD
Norfloxacin—Ataxia—Doxorubicin—thyroid cancer	0.000392	0.00178	CcSEcCtD
Norfloxacin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000391	0.00177	CcSEcCtD
Norfloxacin—Dysphagia—Epirubicin—thyroid cancer	0.00039	0.00176	CcSEcCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—thyroid cancer	0.000387	0.049	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—thyroid cancer	0.000387	0.049	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—thyroid cancer	0.000387	0.049	CbGdCrCtD
Norfloxacin—Eosinophilia—Epirubicin—thyroid cancer	0.000386	0.00175	CcSEcCtD
Norfloxacin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000385	0.00174	CcSEcCtD
Norfloxacin—Pancreatitis—Epirubicin—thyroid cancer	0.000382	0.00173	CcSEcCtD
Norfloxacin—Vomiting—Sorafenib—thyroid cancer	0.000381	0.00173	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000381	0.00172	CcSEcCtD
Norfloxacin—Rash—Sorafenib—thyroid cancer	0.000378	0.00171	CcSEcCtD
Norfloxacin—Dermatitis—Sorafenib—thyroid cancer	0.000378	0.00171	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000376	0.0017	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000376	0.0017	CcSEcCtD
Norfloxacin—Headache—Sorafenib—thyroid cancer	0.000376	0.0017	CcSEcCtD
Norfloxacin—Neutropenia—Epirubicin—thyroid cancer	0.000365	0.00165	CcSEcCtD
Norfloxacin—Dysphagia—Doxorubicin—thyroid cancer	0.000361	0.00163	CcSEcCtD
Norfloxacin—Eosinophilia—Doxorubicin—thyroid cancer	0.000357	0.00162	CcSEcCtD
Norfloxacin—Nausea—Sorafenib—thyroid cancer	0.000356	0.00161	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000356	0.00161	CcSEcCtD
Norfloxacin—Pancreatitis—Doxorubicin—thyroid cancer	0.000354	0.0016	CcSEcCtD
Norfloxacin—Drowsiness—Epirubicin—thyroid cancer	0.000348	0.00157	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000345	0.00156	CcSEcCtD
Norfloxacin—Renal failure—Epirubicin—thyroid cancer	0.000342	0.00155	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000341	0.00154	CcSEcCtD
Norfloxacin—Jaundice—Epirubicin—thyroid cancer	0.000339	0.00153	CcSEcCtD
Norfloxacin—Stomatitis—Epirubicin—thyroid cancer	0.000339	0.00153	CcSEcCtD
Norfloxacin—Conjunctivitis—Epirubicin—thyroid cancer	0.000338	0.00153	CcSEcCtD
Norfloxacin—Neutropenia—Doxorubicin—thyroid cancer	0.000337	0.00153	CcSEcCtD
Norfloxacin—Haematuria—Epirubicin—thyroid cancer	0.000331	0.0015	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000329	0.00149	CcSEcCtD
Norfloxacin—Agranulocytosis—Epirubicin—thyroid cancer	0.000324	0.00147	CcSEcCtD
Norfloxacin—Drowsiness—Doxorubicin—thyroid cancer	0.000322	0.00146	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000319	0.00144	CcSEcCtD
Norfloxacin—Renal failure—Doxorubicin—thyroid cancer	0.000316	0.00143	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000315	0.00143	CcSEcCtD
Norfloxacin—Stomatitis—Doxorubicin—thyroid cancer	0.000314	0.00142	CcSEcCtD
Norfloxacin—Jaundice—Doxorubicin—thyroid cancer	0.000314	0.00142	CcSEcCtD
Norfloxacin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000313	0.00141	CcSEcCtD
Norfloxacin—Hepatitis—Epirubicin—thyroid cancer	0.000312	0.00141	CcSEcCtD
Norfloxacin—Hypoaesthesia—Epirubicin—thyroid cancer	0.00031	0.0014	CcSEcCtD
Norfloxacin—Haematuria—Doxorubicin—thyroid cancer	0.000307	0.00139	CcSEcCtD
Norfloxacin—Visual impairment—Epirubicin—thyroid cancer	0.000301	0.00136	CcSEcCtD
Norfloxacin—Agranulocytosis—Doxorubicin—thyroid cancer	0.0003	0.00136	CcSEcCtD
Norfloxacin—Erythema multiforme—Epirubicin—thyroid cancer	0.000295	0.00134	CcSEcCtD
Norfloxacin—Tinnitus—Epirubicin—thyroid cancer	0.000291	0.00132	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—thyroid cancer	0.000289	0.00131	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000287	0.0013	CcSEcCtD
Norfloxacin—Chills—Epirubicin—thyroid cancer	0.00028	0.00127	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—thyroid cancer	0.000278	0.00126	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000273	0.00124	CcSEcCtD
Norfloxacin—Erythema—Epirubicin—thyroid cancer	0.000272	0.00123	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—thyroid cancer	0.000269	0.00122	CcSEcCtD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCDC6—thyroid cancer	0.000269	0.108	CbGpPWpGaD
Norfloxacin—Flatulence—Epirubicin—thyroid cancer	0.000268	0.00121	CcSEcCtD
Norfloxacin—Tension—Epirubicin—thyroid cancer	0.000267	0.00121	CcSEcCtD
Norfloxacin—Dysgeusia—Epirubicin—thyroid cancer	0.000266	0.0012	CcSEcCtD
Norfloxacin—Nervousness—Epirubicin—thyroid cancer	0.000264	0.00119	CcSEcCtD
Norfloxacin—Back pain—Epirubicin—thyroid cancer	0.000263	0.00119	CcSEcCtD
Norfloxacin—Muscle spasms—Epirubicin—thyroid cancer	0.000261	0.00118	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—thyroid cancer	0.000259	0.00117	CcSEcCtD
Norfloxacin—Vision blurred—Epirubicin—thyroid cancer	0.000256	0.00116	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—thyroid cancer	0.000251	0.00114	CcSEcCtD
Norfloxacin—Agitation—Epirubicin—thyroid cancer	0.00025	0.00113	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—thyroid cancer	0.000248	0.00112	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—thyroid cancer	0.000247	0.00112	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—thyroid cancer	0.000246	0.00111	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—thyroid cancer	0.000244	0.0011	CcSEcCtD
Norfloxacin—Vertigo—Epirubicin—thyroid cancer	0.000244	0.0011	CcSEcCtD
Norfloxacin—Leukopenia—Epirubicin—thyroid cancer	0.000243	0.0011	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—thyroid cancer	0.000243	0.0011	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—thyroid cancer	0.000242	0.00109	CcSEcCtD
Norfloxacin—Palpitations—Epirubicin—thyroid cancer	0.00024	0.00109	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—thyroid cancer	0.000237	0.00107	CcSEcCtD
Norfloxacin—Convulsion—Epirubicin—thyroid cancer	0.000235	0.00106	CcSEcCtD
Norfloxacin—Chest pain—Epirubicin—thyroid cancer	0.000231	0.00105	CcSEcCtD
Norfloxacin—Myalgia—Epirubicin—thyroid cancer	0.000231	0.00105	CcSEcCtD
Norfloxacin—Arthralgia—Epirubicin—thyroid cancer	0.000231	0.00105	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—thyroid cancer	0.000231	0.00105	CcSEcCtD
Norfloxacin—Anxiety—Epirubicin—thyroid cancer	0.00023	0.00104	CcSEcCtD
Norfloxacin—Dry mouth—Epirubicin—thyroid cancer	0.000226	0.00102	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—thyroid cancer	0.000226	0.00102	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—thyroid cancer	0.000225	0.00102	CcSEcCtD
Norfloxacin—Confusional state—Epirubicin—thyroid cancer	0.000224	0.00101	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—thyroid cancer	0.000222	0.00101	CcSEcCtD
Norfloxacin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000222	0.001	CcSEcCtD
Norfloxacin—Oedema—Epirubicin—thyroid cancer	0.000222	0.001	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—thyroid cancer	0.000218	0.000985	CcSEcCtD
Norfloxacin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000217	0.000982	CcSEcCtD
Norfloxacin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000214	0.00097	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—thyroid cancer	0.000214	0.000968	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—thyroid cancer	0.000214	0.000968	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—thyroid cancer	0.000214	0.000968	CcSEcCtD
Norfloxacin—Anxiety—Doxorubicin—thyroid cancer	0.000213	0.000965	CcSEcCtD
Norfloxacin—Anorexia—Epirubicin—thyroid cancer	0.000211	0.000956	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—thyroid cancer	0.000209	0.000947	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—thyroid cancer	0.000207	0.000936	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—thyroid cancer	0.000205	0.000928	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000205	0.000928	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000202	0.000914	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000201	0.000909	CcSEcCtD
Norfloxacin—Insomnia—Epirubicin—thyroid cancer	0.000201	0.000907	CcSEcCtD
Norfloxacin—Paraesthesia—Epirubicin—thyroid cancer	0.000199	0.000901	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000198	0.000897	CcSEcCtD
Norfloxacin—Dyspnoea—Epirubicin—thyroid cancer	0.000198	0.000894	CcSEcCtD
Norfloxacin—Somnolence—Epirubicin—thyroid cancer	0.000197	0.000892	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—thyroid cancer	0.000196	0.000885	CcSEcCtD
Norfloxacin—Dyspepsia—Epirubicin—thyroid cancer	0.000195	0.000883	CcSEcCtD
Norfloxacin—Decreased appetite—Epirubicin—thyroid cancer	0.000193	0.000872	CcSEcCtD
Norfloxacin—Fatigue—Epirubicin—thyroid cancer	0.000191	0.000865	CcSEcCtD
Norfloxacin—Constipation—Epirubicin—thyroid cancer	0.00019	0.000858	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000187	0.000846	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—thyroid cancer	0.000186	0.00084	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—thyroid cancer	0.000184	0.000833	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—thyroid cancer	0.000183	0.000828	CcSEcCtD
Norfloxacin—Feeling abnormal—Epirubicin—thyroid cancer	0.000183	0.000827	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—thyroid cancer	0.000182	0.000825	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000181	0.00082	CcSEcCtD
Norfloxacin—Dyspepsia—Doxorubicin—thyroid cancer	0.000181	0.000817	CcSEcCtD
Norfloxacin—Decreased appetite—Doxorubicin—thyroid cancer	0.000178	0.000807	CcSEcCtD
Norfloxacin—Fatigue—Doxorubicin—thyroid cancer	0.000177	0.0008	CcSEcCtD
Norfloxacin—Urticaria—Epirubicin—thyroid cancer	0.000176	0.000797	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—thyroid cancer	0.000175	0.000794	CcSEcCtD
Norfloxacin—Abdominal pain—Epirubicin—thyroid cancer	0.000175	0.000793	CcSEcCtD
Norfloxacin—Body temperature increased—Epirubicin—thyroid cancer	0.000175	0.000793	CcSEcCtD
Norfloxacin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000169	0.000765	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000168	0.000759	CcSEcCtD
Norfloxacin—Hypersensitivity—Epirubicin—thyroid cancer	0.000163	0.000739	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—thyroid cancer	0.000163	0.000737	CcSEcCtD
Norfloxacin—Body temperature increased—Doxorubicin—thyroid cancer	0.000162	0.000734	CcSEcCtD
Norfloxacin—Abdominal pain—Doxorubicin—thyroid cancer	0.000162	0.000734	CcSEcCtD
Norfloxacin—Asthenia—Epirubicin—thyroid cancer	0.000159	0.00072	CcSEcCtD
Norfloxacin—Pruritus—Epirubicin—thyroid cancer	0.000157	0.00071	CcSEcCtD
Norfloxacin—Diarrhoea—Epirubicin—thyroid cancer	0.000152	0.000686	CcSEcCtD
Norfloxacin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000151	0.000684	CcSEcCtD
Norfloxacin—Asthenia—Doxorubicin—thyroid cancer	0.000147	0.000666	CcSEcCtD
Norfloxacin—Dizziness—Epirubicin—thyroid cancer	0.000147	0.000663	CcSEcCtD
Norfloxacin—Pruritus—Doxorubicin—thyroid cancer	0.000145	0.000657	CcSEcCtD
Norfloxacin—Vomiting—Epirubicin—thyroid cancer	0.000141	0.000638	CcSEcCtD
Norfloxacin—Diarrhoea—Doxorubicin—thyroid cancer	0.00014	0.000635	CcSEcCtD
Norfloxacin—Rash—Epirubicin—thyroid cancer	0.00014	0.000633	CcSEcCtD
Norfloxacin—Dermatitis—Epirubicin—thyroid cancer	0.00014	0.000632	CcSEcCtD
Norfloxacin—Headache—Epirubicin—thyroid cancer	0.000139	0.000628	CcSEcCtD
Norfloxacin—Dizziness—Doxorubicin—thyroid cancer	0.000136	0.000614	CcSEcCtD
Norfloxacin—Nausea—Epirubicin—thyroid cancer	0.000132	0.000596	CcSEcCtD
Norfloxacin—Vomiting—Doxorubicin—thyroid cancer	0.00013	0.00059	CcSEcCtD
Norfloxacin—Rash—Doxorubicin—thyroid cancer	0.000129	0.000585	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—thyroid cancer	0.000129	0.000585	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—thyroid cancer	0.000129	0.000581	CcSEcCtD
Norfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TCF7L1—thyroid cancer	0.000128	0.0513	CbGpPWpGaD
Norfloxacin—Nausea—Doxorubicin—thyroid cancer	0.000122	0.000551	CcSEcCtD
Norfloxacin—TOP2A—G0 and Early G1—CDK1—thyroid cancer	0.000105	0.0421	CbGpPWpGaD
Norfloxacin—CYP1A1—Arachidonic acid metabolism—HPGD—thyroid cancer	6.38e-05	0.0256	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—RET—thyroid cancer	6.24e-05	0.0251	CbGpPWpGaD
Norfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NRG1—thyroid cancer	5.08e-05	0.0204	CbGpPWpGaD
Norfloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	5.01e-05	0.0201	CbGpPWpGaD
Norfloxacin—CYP2A6—Fluoropyrimidine Activity—SMUG1—thyroid cancer	4.8e-05	0.0193	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—NKX2-1—thyroid cancer	4.53e-05	0.0182	CbGpPWpGaD
Norfloxacin—CYP2A6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	4.42e-05	0.0178	CbGpPWpGaD
Norfloxacin—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	4.26e-05	0.0171	CbGpPWpGaD
Norfloxacin—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	4.11e-05	0.0165	CbGpPWpGaD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	4.07e-05	0.0163	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	3.98e-05	0.016	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK1—thyroid cancer	3.87e-05	0.0155	CbGpPWpGaD
Norfloxacin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—thyroid cancer	3.82e-05	0.0154	CbGpPWpGaD
Norfloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	3.78e-05	0.0152	CbGpPWpGaD
Norfloxacin—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	3.49e-05	0.014	CbGpPWpGaD
Norfloxacin—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	3.08e-05	0.0124	CbGpPWpGaD
Norfloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.92e-05	0.0117	CbGpPWpGaD
Norfloxacin—CYP1A1—Metapathway biotransformation—CHST14—thyroid cancer	2.91e-05	0.0117	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK1—thyroid cancer	2.72e-05	0.0109	CbGpPWpGaD
Norfloxacin—CYP2A6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.67e-05	0.0107	CbGpPWpGaD
Norfloxacin—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	2.46e-05	0.00988	CbGpPWpGaD
Norfloxacin—TOP2A—Gastric Cancer Network 2—TP53—thyroid cancer	2.42e-05	0.00973	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—PCM1—thyroid cancer	2.41e-05	0.00969	CbGpPWpGaD
Norfloxacin—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.37e-05	0.0095	CbGpPWpGaD
Norfloxacin—SLC22A5—SLC-mediated transmembrane transport—CP—thyroid cancer	2.28e-05	0.00915	CbGpPWpGaD
Norfloxacin—SLC22A5—SLC-mediated transmembrane transport—TPR—thyroid cancer	2.28e-05	0.00915	CbGpPWpGaD
Norfloxacin—CYP2A6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.17e-05	0.00871	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—PCM1—thyroid cancer	2.16e-05	0.00866	CbGpPWpGaD
Norfloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	2.11e-05	0.00847	CbGpPWpGaD
Norfloxacin—CYP1A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.99e-05	0.008	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	1.91e-05	0.00769	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	1.85e-05	0.00744	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—CP—thyroid cancer	1.72e-05	0.00691	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—TPR—thyroid cancer	1.72e-05	0.00691	CbGpPWpGaD
Norfloxacin—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.71e-05	0.00687	CbGpPWpGaD
Norfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	1.71e-05	0.00685	CbGpPWpGaD
Norfloxacin—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	1.62e-05	0.00651	CbGpPWpGaD
Norfloxacin—CYP1A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.62e-05	0.00649	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—thyroid cancer	1.61e-05	0.00647	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—SLC5A5—thyroid cancer	1.56e-05	0.00628	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—TPR—thyroid cancer	1.47e-05	0.00592	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	1.43e-05	0.00575	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TPR—thyroid cancer	1.32e-05	0.00529	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—RXRA—thyroid cancer	1.31e-05	0.00527	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	1.29e-05	0.00517	CbGpPWpGaD
Norfloxacin—CYP2A6—Fluoropyrimidine Activity—TP53—thyroid cancer	1.28e-05	0.00512	CbGpPWpGaD
Norfloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	1.27e-05	0.0051	CbGpPWpGaD
Norfloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	1.26e-05	0.00508	CbGpPWpGaD
Norfloxacin—CYP3A7—Biological oxidations—RXRA—thyroid cancer	1.26e-05	0.00505	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—RXRA—thyroid cancer	1.23e-05	0.00493	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	1.22e-05	0.00492	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—thyroid cancer	1.2e-05	0.00482	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—PPARG—thyroid cancer	1.16e-05	0.00466	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—TPR—thyroid cancer	1.16e-05	0.00465	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—CP—thyroid cancer	1.16e-05	0.00465	CbGpPWpGaD
Norfloxacin—CYP2A6—Biological oxidations—RXRA—thyroid cancer	1.15e-05	0.00463	CbGpPWpGaD
Norfloxacin—CYP1A1—Arachidonic acid metabolism—PTGS2—thyroid cancer	1.15e-05	0.0046	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.14e-05	0.00457	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—NRG1—thyroid cancer	1.14e-05	0.00456	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—thyroid cancer	1.13e-05	0.00455	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—thyroid cancer	1.06e-05	0.00426	CbGpPWpGaD
Norfloxacin—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	1.03e-05	0.00414	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDK1—thyroid cancer	9.98e-06	0.00401	CbGpPWpGaD
Norfloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	9.81e-06	0.00394	CbGpPWpGaD
Norfloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	9.75e-06	0.00392	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	9.53e-06	0.00383	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	9.51e-06	0.00382	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MINPP1—thyroid cancer	9.23e-06	0.00371	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	9.12e-06	0.00366	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—RXRA—thyroid cancer	9.08e-06	0.00365	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDK1—thyroid cancer	8.93e-06	0.00359	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	8.74e-06	0.00351	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	8.74e-06	0.00351	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.67e-06	0.00348	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.6e-06	0.00345	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.59e-06	0.00345	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—RXRA—thyroid cancer	8.58e-06	0.00345	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MINPP1—thyroid cancer	8.46e-06	0.0034	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.29e-06	0.00333	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—thyroid cancer	8.28e-06	0.00332	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	8.2e-06	0.00329	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—PTEN—thyroid cancer	7.96e-06	0.0032	CbGpPWpGaD
Norfloxacin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	7.95e-06	0.00319	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NDUFA13—thyroid cancer	7.85e-06	0.00315	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	7.81e-06	0.00314	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—PPARG—thyroid cancer	7.75e-06	0.00311	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	7.58e-06	0.00305	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CHST14—thyroid cancer	7.38e-06	0.00296	CbGpPWpGaD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	7.3e-06	0.00293	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.28e-06	0.00292	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NDUFA13—thyroid cancer	7.19e-06	0.00289	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	6.97e-06	0.0028	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CHST14—thyroid cancer	6.76e-06	0.00272	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MINPP1—thyroid cancer	6.67e-06	0.00268	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.54e-06	0.00263	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TERT—thyroid cancer	6.43e-06	0.00258	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.37e-06	0.00256	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MINPP1—thyroid cancer	6.3e-06	0.00253	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	6.07e-06	0.00244	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—HPGD—thyroid cancer	5.95e-06	0.00239	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.82e-06	0.00234	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NDUFA13—thyroid cancer	5.67e-06	0.00228	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.66e-06	0.00227	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.5e-06	0.00221	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—RXRA—thyroid cancer	5.47e-06	0.0022	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—HPGD—thyroid cancer	5.45e-06	0.00219	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—thyroid cancer	5.43e-06	0.00218	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NDUFA13—thyroid cancer	5.36e-06	0.00215	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CHST14—thyroid cancer	5.33e-06	0.00214	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	5.23e-06	0.0021	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	5.22e-06	0.0021	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CHST14—thyroid cancer	5.04e-06	0.00202	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.78e-06	0.00192	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	4.44e-06	0.00178	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HPGD—thyroid cancer	4.3e-06	0.00173	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	4.22e-06	0.0017	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—thyroid cancer	4.16e-06	0.00167	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HPGD—thyroid cancer	4.06e-06	0.00163	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MINPP1—thyroid cancer	4.02e-06	0.00161	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND1—thyroid cancer	3.72e-06	0.00149	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NDUFA13—thyroid cancer	3.42e-06	0.00137	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—TPR—thyroid cancer	3.42e-06	0.00137	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	3.36e-06	0.00135	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.3e-06	0.00132	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CHST14—thyroid cancer	3.21e-06	0.00129	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TPR—thyroid cancer	3.13e-06	0.00126	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.1e-06	0.00125	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	3.08e-06	0.00124	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.64e-06	0.00106	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HPGD—thyroid cancer	2.59e-06	0.00104	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC5A5—thyroid cancer	2.56e-06	0.00103	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CHST14—thyroid cancer	2.48e-06	0.000996	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TPR—thyroid cancer	2.47e-06	0.000992	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—thyroid cancer	2.45e-06	0.000984	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.43e-06	0.000976	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC5A5—thyroid cancer	2.34e-06	0.000942	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TPR—thyroid cancer	2.33e-06	0.000937	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	2.3e-06	0.000922	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—RXRA—thyroid cancer	2.15e-06	0.000863	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.1e-06	0.000844	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.08e-06	0.000836	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HPGD—thyroid cancer	2e-06	0.000803	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—RXRA—thyroid cancer	1.97e-06	0.000791	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.85e-06	0.000743	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.75e-06	0.000702	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.64e-06	0.000657	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—RXRA—thyroid cancer	1.55e-06	0.000624	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TPR—thyroid cancer	1.49e-06	0.000598	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—RXRA—thyroid cancer	1.47e-06	0.000589	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.46e-06	0.000588	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.43e-06	0.000573	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARG—thyroid cancer	1.36e-06	0.000545	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.33e-06	0.000533	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARG—thyroid cancer	1.24e-06	0.0005	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TPR—thyroid cancer	1.15e-06	0.000461	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.13e-06	0.000454	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.11e-06	0.000447	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.07e-06	0.000429	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.04e-06	0.000419	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARG—thyroid cancer	9.81e-07	0.000394	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—thyroid cancer	9.78e-07	0.000393	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—RXRA—thyroid cancer	9.36e-07	0.000376	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTEN—thyroid cancer	9.31e-07	0.000374	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARG—thyroid cancer	9.27e-07	0.000372	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.1e-07	0.000366	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	8.6e-07	0.000345	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTEN—thyroid cancer	8.53e-07	0.000343	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—thyroid cancer	7.72e-07	0.00031	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—thyroid cancer	7.29e-07	0.000293	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—RXRA—thyroid cancer	7.22e-07	0.00029	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTEN—thyroid cancer	6.73e-07	0.00027	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTEN—thyroid cancer	6.36e-07	0.000255	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARG—thyroid cancer	5.91e-07	0.000237	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—thyroid cancer	5.36e-07	0.000215	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—thyroid cancer	4.92e-07	0.000198	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—thyroid cancer	4.65e-07	0.000187	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARG—thyroid cancer	4.56e-07	0.000183	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTEN—thyroid cancer	4.05e-07	0.000163	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—thyroid cancer	3.88e-07	0.000156	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AKT1—thyroid cancer	3.66e-07	0.000147	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.59e-07	0.000144	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTEN—thyroid cancer	3.13e-07	0.000126	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKT1—thyroid cancer	2.34e-07	9.38e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—thyroid cancer	1.8e-07	7.24e-05	CbGpPWpGaD
